556 related articles for article (PubMed ID: 20370748)
21. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus.
Chuck EA; Frazee BW; Lambert L; McCabe R
J Emerg Med; 2010 Jun; 38(5):567-71. PubMed ID: 18514468
[TBL] [Abstract][Full Text] [Related]
22. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.
Lee MC; Rios AM; Aten MF; Mejias A; Cavuoti D; McCracken GH; Hardy RD
Pediatr Infect Dis J; 2004 Feb; 23(2):123-7. PubMed ID: 14872177
[TBL] [Abstract][Full Text] [Related]
23. Changes in community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections presenting to the pediatric emergency department: comparing 2003 to 2008.
Karamatsu ML; Thorp AW; Brown L
Pediatr Emerg Care; 2012 Feb; 28(2):131-5. PubMed ID: 22270497
[TBL] [Abstract][Full Text] [Related]
24. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Guss J; Kazahaya K
Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):943-8. PubMed ID: 17418426
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous methicillin-resistant Staphylococcus aureus in a suburban community hospital pediatric emergency department.
Kairam N; Silverman ME; Salo DF; Baorto E; Lee B; Amato CS
J Emerg Med; 2011 Nov; 41(5):460-5. PubMed ID: 19592187
[TBL] [Abstract][Full Text] [Related]
26. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.
Hersh AL; Chambers HF; Maselli JH; Gonzales R
Arch Intern Med; 2008 Jul; 168(14):1585-91. PubMed ID: 18663172
[TBL] [Abstract][Full Text] [Related]
27. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Crawford SE; David MZ; Glikman D; King KJ; Boyle-Vavra S; Daum RS
J Am Board Fam Med; 2009; 22(6):647-54. PubMed ID: 19897693
[TBL] [Abstract][Full Text] [Related]
28. Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong.
Ho PL; Chuang SK; Choi YF; Lee RA; Lit AC; Ng TK; Que TL; Shek KC; Tong HK; Tse CW; Tung WK; Yung RW;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):245-50. PubMed ID: 18272316
[TBL] [Abstract][Full Text] [Related]
29. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Chambers HF
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
[TBL] [Abstract][Full Text] [Related]
30. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
Ruhe JJ; Smith N; Bradsher RW; Menon A
Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.
Bruce AM; Spencer JM
J Drugs Dermatol; 2008 Aug; 7(8):751-5. PubMed ID: 18720691
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.
Frazee BW; Lynn J; Charlebois ED; Lambert L; Lowery D; Perdreau-Remington F
Ann Emerg Med; 2005 Mar; 45(3):311-20. PubMed ID: 15726056
[TBL] [Abstract][Full Text] [Related]
33. Characterization of community-acquired Staphylococcus aureus infections in children.
Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
[TBL] [Abstract][Full Text] [Related]
34. Trends in emergency department management of skin abscesses.
Prusakowski MK; Kuehl DR
Am J Infect Control; 2015 Apr; 43(4):336-40. PubMed ID: 25726132
[TBL] [Abstract][Full Text] [Related]
35. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
36. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
37. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
Le J; Lieberman JM
Pharmacotherapy; 2006 Dec; 26(12):1758-70. PubMed ID: 17125437
[TBL] [Abstract][Full Text] [Related]
38. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department.
Pickett A; Wilkinson M; Menoch M; Snell J; Yniguez R; Bulloch B
Pediatr Emerg Care; 2009 Dec; 25(12):831-4. PubMed ID: 19952975
[TBL] [Abstract][Full Text] [Related]
39. Three-year surveillance of community-acquired Staphylococcus aureus infections in children.
Kaplan SL; Hulten KG; Gonzalez BE; Hammerman WA; Lamberth L; Versalovic J; Mason EO
Clin Infect Dis; 2005 Jun; 40(12):1785-91. PubMed ID: 15909267
[TBL] [Abstract][Full Text] [Related]
40. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections.
Yang ES; Tan J; Eells S; Rieg G; Tagudar G; Miller LG
Clin Microbiol Infect; 2010 May; 16(5):425-31. PubMed ID: 19689469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
